Laurion Capital Management LP Gritstone Bio, Inc. Transaction History

Laurion Capital Management LP

  • $7.27 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 08, 2019
SELL
$9.97 - $18.96 $763,831 - $1.45 Million
-76,613 Closed
0 $0
Q4 2018

Feb 14, 2019
SELL
$11.61 - $31.1 $561,773 - $1.5 Million
-48,387 Reduced 38.71%
76,613 $1.18 Million
Q3 2018

Nov 13, 2018
BUY
$14.24 - $14.24 $1.78 Million - $1.78 Million
125,000 New
125,000 $1.78 Million

Others Institutions Holding GRTS

# of Institutions
62
Shares Held
35.4M
Call Options Held
395K
Put Options Held
132K
View Full List

About Gritstone bio, Inc.

GRTS Quotes by TradingView
  • Ticker GRTS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 73,006,896
  • Market Cap $2.19M
  • Description
  • Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder ...
More about GRTS
Track This Portfolio

Track Laurion Capital Management LP Portfolio

Follow Laurion Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Laurion Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email